Opus Point Partners Management LLC

Search
⚲

Opus Point Partners Management LLC ✚
CRD #	161996
SEC #	802-76334
CIK #	0001503454, 0001600175
AUM
Employees
Phone	212-554-4504
Address	2 Gansevoort Street New York, NY 10014
Source	[IAPD] [EDGAR] [Website]

Total AUM ($) Copy

Sector	Form 13F Holdings	Value ($M)
	Mettler Toledo International INC/	2.3
	Bristol Myers Squibb Co	1.7
	Illumina Inc	1.4
	Vertex Pharmaceuticals Inc / Ma	1.4
	ISIS Pharmaceuticals Inc	1.2
	Alnylam Pharmaceuticals Inc	1.1
	Qiagen NV	1.0
	Coronado Biosciences Inc	0.9
	Proqr Therapeutics NV	0.8
	Incyte Corp	0.8
View All

Holdings by Sector ($M)

Type	Form D Funds	Date	Sold	AUM
HF	Opus Point Biotechnology Fund LLC	2015-03-31		7.4 M
HF	Opus Point Healthcare Value Fund LP	[2013-05-14]		8.2 M
	Filed 2008-11-25 (D) · Exemption 506 · Minimum $2,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Over $100,000,000
HF	Opus Point Healthcare Innovations Fund LP	[2012-04-02]	89.8 M	77.8 M
	Filed 2020-05-20 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $2,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Opus Point Healthcare Innovations Offshore Fund Limited	[2012-04-02]	33.1 M	33.2 M
	Filed 2020-07-21 (D/A) · Exemption 506(b) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets No Aggregate Net Asset Value
HF	Opus Point Healthcare Low Net Fund LP	[2012-04-02]		7.0 M
	Filed 2008-10-14 (D) · Exemption 506 · Minimum $2,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Over $100,000,000

AUM Breakdown	Accounts	AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	0	0.0
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	0	0.0
By Discretionary
Discretionary	0	0.0
Non-Discretionary	0	0.0
Total	0	0.0
By Non-United States Persons
Non-United States Persons		0.0
United States Persons		0.0
Total	0	0.0

Form D Directors	Role	# Filings	# Firms
Wade Kenny	Director	86	31
Dawn Cummings	Director	13	7
Michael Weiss	Director, Executive Officer	66	5
Lindsay Rosenwald	Executive Officer	25	2
Lindsay Rosenwald MD	Director	6	2
Opus Point Healthcare Fund GP LLC	Promoter	2	1
NA Opus Point Healthcare Fund GP LLC	Promoter	1	1
Kevin Philips	Director	1	1

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Opus Point Partners LLC	Anthera Pharmaceuticals Inc	[2012-08-27]
Opus Point Partners LLC	Manhattan Pharmaceuticals Inc	[2012-01-10]

Firm Profile (Form ADV)
Fund Types	Hedge Fund

Form 3/4/5 Subject	2011 - 2026
Opus Point Healthcare Innovations Offshore Fund Ltd
FBIO Acquisition Inc
Coronado Biosciences Inc
Opus Point Partners LLC
National Holdings Corp
Weiss Michael S
Rosenwald Lindsay A MD
TG Therapeutics Inc

Assets, Funds, Holdings